Tuberculosis: a timeless challenge for medicine
pdf

Keywords

History of Tuberculosis
History of drug resistance
social history of tuberculosis

Abstract

History of Medicine is not a discipline destined to culturally enrich only those who work in the health sector. All historians know very well how some medical events have influenced the course of history. In particular, infectious diseases, being interconnected with political, social, economic and war issues, have an important historical significance.
Microbial agents are invisible enemies ready to undermine mankind and to find prosperity in human misery.
Tuberculosis, better than other, is well suited to study the epistemological path of medical thought, from its origins to the present day.
From the Hippocratic and Galenic thought to the anatomo-clinical method, from the advent of microbiology to the antibiotic era up to the postantibiotic era, recognizing the timeless need to implement valid social policies and effective preventive medicine actions to achieve satisfactory results.

https://doi.org/10.15167/2421-4248/jpmh2020.61.1.1402
pdf

References

1. Armocida E, Nicoli Aldini N. Teaching and learning the History of Medicine in the university: some considerations after the students’ final exams. Medicina Historica 2018; 2(1): 41-48.
2. Ligon, BL. Plague: a review of its history and potential as a biological weapon.Seminars in pediatric infectious diseases. 2006;17(3):161-170.
3. Martini M, Gazzaniga V, Barberis I, Bragazzi NL, Parodi A, & Armocida E. De morbo gallico omnia quae extant apud omnes medicos cuiuscunque nationis: the sixteenth-century collection of Luigi Luigini. Le infezioni in medicina, 2019;27(3):350-352.
4. Reid AH, Taubenberger JK, & Fanning TG. The 1918 Spanish influenza: integrating history and biology. Microbes and infection. 2001; 3(1):81-87.
5. Daniel T M. The history of tuberculosis. Respiratory medicine. 2006;100(11):1862-1870.
6. Kapur V, Whittam TS, & Musser JM. Is Mycobacterium tuberculosis 15,000 years old?. Journal of Infectious Diseases. 1994;170(5):1348-1349.
7. Brosch R, et al. A new evolutionary scenario for the Mycobacterium tuberculosis. complex. Proceedings of the national academy of Sciences. 2002;99(6):3684-3689.
8. Armocida E, Böni T, Rühli FJ, Galassi FM. Does acromegaly suffice to explain the origin of Pulcinella? A novel interpretation. Eur J Intern Med. 2016 Mar;28:e16-7
9. Coar T. The aphorisms of Hippocrates: with a translation into latin, and english. Classics of Medicine Library. 1982
10. Major RH. (Ed.) Classic descriptions of disease: with biographical sketches of the authors. Charles C. Thomas Publisher.1945
11. Daniel TM. Pioneers of medicine and their impact on tuberculosis. University Rochester Press.2000
12. Doetsch, R. N. (1978). Benjamin Marten and his" New Theory of Consumptions". Microbiological reviews, 42(3),521-528.
13. Barberis I, Bragazzi, NL, Galluzzo L, & Martini M. The history of tuberculosis: from the first historical records to the isolation of Koch's bacillus. Journal of preventive medicine and hygiene. 2017;58(1):E9-E12.
14. Blevins SM, & Bronze MS. Robert Koch and the ‘golden age’of bacteriology. International Journal of Infectious Diseases. 2010;14(9):e744-e751.
15. Koch R. The aetiology of tuberculosis. New York: National Tuberculosis Association, 1932:47.
16. Gradmann C. Robert Koch and the pressures of scientific research: tuberculosis and tuberculin. Medical history. 2001;45(1): 1-32.
17. Martini M, Gazzaniga V, Behzadifar M, Bragazzi NL, & Barberis I. The history of tuberculosis: the social role of sanatoria for the treatment of tuberculosis in Italy between the end of the 19th century and the middle of the 20th. Journal of preventive medicine and hygiene. 2018; 59(4): E323-E327.
18. Armocida E, Martini M. Neurotuberculosis at the time of Anna O.: life prospects. Journal of the neurological science. 2019; 402: 86-87.
19. Sabbatani S. La nascita dei sanatori e lo sviluppo socio-sanitario in Europa ed in Italia. Le infezioni in Medicina. 2005;(2): 123-132.
20. Connolly C. The TB preventorium. AJN The American Journal of Nursing. 2000; 100(10), 62-65.
21. Sakula A. Carlo Forlanini, inventor of artificial pneumothorax for treatment of pulmonary tuberculosis. Thorax. 1983; 38(5): 326-332.
22. Hansson N, & Polianski IJ. Therapeutic pneumothorax and the Nobel Prize. The Annals of thoracic surgery. 2015;100(2): 761-765.
23. Luca S, & Mihaescu T. History of BCG Vaccine. Maedica (Buchar). 2013;8(1): 53–58.
24. Keshavjee S, Farmer PE. Tuberculosis, drug resistance, and the history of modern medicine. New England Journal of Medicine. 2012; 367(10): 931-936.
25. Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. Br Med J 1948;2:769-782
26. Armocida E, Nicoli Aldini N. Anton Spartaco Roversi: il medico ideatore del “Roversino”. Biografie Mediche. 2018; 8: 19-24
27. Castro KG, LoBue P. Bridging implementation, knowledge, and ambition gaps to eliminate tuberculosis in the United States and globally. Emerg Infect Dis 2011;17:337-342
28. Global Tuberculosis Report 2018. World Health Organization. Available at: http://www.who.int/tb/publications/global_report/en/ [Accessed on 06/10/2019].